Dermatology Book

//fpnotebook.com/

Necrotizing Soft Tissue Infection

Aka: Necrotizing Soft Tissue Infection, Necrotizing Fasciitis, Fournier's Gangrene, Fournier's Scrotal Gangrene, Necrotizing Streptococcal Fasciitis
  1. See Also
    1. Cellulitis
    2. Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC Score)
  2. Definitions
    1. Necrotizing Fasciitis
      1. Rapidly progressive, deep subcutaneous infection resulting in tissue necrosis and systemic toxicity
    2. Fournier's Gangrene
      1. Massive infection and swelling of Scrotum and penis
      2. Extends into perineum or abdominal wall, and legs
      3. Seen in Alcoholic Liver Disease or Cirrhosis, Diabetes Mellitus, IV Drug Abuse
  3. Precautions
    1. Necrotizing Fasciitis is a life threatening infection with an insidious, occult presentation
    2. Do not ignore pain out of proportion, Sinus Tachycardia or unexplained fever
    3. Do not delay surgical exploration when Necrotizing Fasciitis is suspected
    4. Physical exam, labs and imaging are unreliable alone at excluding Necrotizing Fasciitis
  4. Pathophysiology
    1. Typically starts with break in skin (e.g. Trauma or recent surgery)
    2. Infection spreads between fascia and subcutaneous tissue
    3. Fibrous bands prevent infectious spread
      1. Present in head and distal extremities
      2. Lacking in trunk and proximal extremities
  5. Risk factors
    1. Age over 50 years
    2. Malnutrition
      1. Hypoalbuminemia
      2. Alcoholism
      3. Cirrhosis (esp. Vibrio vulnificans from seafood)
        1. Liver disease is associated with higher mortality
    3. Immunocompromised state (esp. Neutropenia)
      1. Cancer
      2. Corticosteroid use
      3. HIV Infection
    4. Poor vascular supply
      1. Cardiovascular disease
      2. Peripheral Vascular Disease
      3. Diabetes Mellitus
        1. Most common comorbidity (present in 45% of cases)
        2. Higher amputation risk
        3. Diabetic Neuropathy may result in less recognition of pain
    5. Skin Trauma within last 90 days
      1. Burn Injury
      2. Trauma
      3. Intravenous Drug Abuse
      4. Recent surgery
      5. Alcohol Abuse
    6. Miscellaneous risk factors
      1. Obesity
    7. Break in Gastrointestinal or Genitourinary mucosa
      1. Colon Cancer
      2. Diverticula
      3. Hemorrhoids or Anal Fissure
      4. Urethral tear
      5. Cirrhosis
  6. Findings: Symptoms and Signs progression (in order of occurrence)
    1. Pain out of proportion to physical findings (79%)
    2. Unexplained fever (40%)
    3. Tachycardia (60%)
    4. Swelling (80% of cases)
    5. Foul odor
    6. Subcutaneous air with crepitation (pathognomonic, but late finding)
    7. Rapid progression
    8. Brawny Edema and tenderness
    9. Erythema with indistinct margins
    10. Dark red induration
    11. "Dish water" wound drainage
    12. Involved area may parodoxically be without sensation
    13. Bullae filled with blue or purple fluid
    14. Skin friable, bluish, maroon, or black
    15. Extensive thrombosis of dermal blood vessels
    16. Extension to deep fascia leads to brown-gray appearance
    17. Rapid spread along fascial planes, veins and lymph
    18. Toxicity, shock, and multi-organ failure
  7. Signs: Distribution
    1. Extremities (53%)
    2. Perineum or buttocks (20%, especially in Diabetes Mellitus, Alcoholism)
    3. Trunk (18%)
    4. Head and neck (9%)
    5. References
      1. Bosshardt (1996) Arch Surg 131:846-52 [PubMed]
  8. Exam
    1. Mark the erythematous border of infection
      1. Mark the time of each consecutive margin re-evaluation
  9. Types
    1. Polymicrobial (Type 1) - Mixed aerobic and Anaerobic Bacteria
      1. Break in Gastrointestinal or Genitourinary mucosa or on trunk and extremities
      2. Includes Fournier's Gangrene
      3. Comorbid conditions associated with mixed infection
        1. Diabetes Mellitus
        2. Peripheral Vascular Disease
        3. Immunocompromised state
      4. Typically a combination of anaerobic and aerobic Bacteria
        1. Anaerobic Bacteria include Bacteroides, Clostridium, peptostreptococcus
        2. Aerobic Bacteria include E. coli, Klebsiella, Enterobacter and Proteus
    2. Monomicrobial (Type 2)
      1. Causes
        1. Group A Streptococcus (Streptococcus Pyogenes)
        2. Staphylococcus aureus
        3. Vibrio vulnificus
      2. Begins deep at non-penetrating minor Trauma in typically healthy patients
        1. Risk Factors include IV Drug Abuse and skin popping
        2. May also be associated with Toxic Shock Syndrome
        3. Contusion seeded by transient bacteremia
      3. Findings
        1. Gas production only if mixed infection
        2. Severe toxicity, renal Impairment may precede shock
        3. Myositis in 20-40% cases
        4. Creatine Phosphokinase (CPK) is markedly elevated
        5. Mortality: 20-50% despite Penicillin
  10. Causes: Bacteria
    1. Group A Streptococcus (Streptococcus Pyogenes)
    2. Staphylococcus aureus
    3. Clostridium perfringens
      1. Hyperbaric Oxygen treatment may help in Gas Gangrene
    4. Vibrio haemlyticus or Vibrio vulnificus (sea water exposure, seafood ingestion esp. in Cirrhosis)
    5. Aeromonas (fresh water exposure)
    6. Plesiomonas (fresh water exposure)
    7. Superinfection of varicella in children
    8. Omphalitis (Umbilical Cord stump infection) in newborns
  11. Diagnosis: Findings Suggestive of Necrotizing Fasciitis
    1. Altered Mental Status
    2. Soft tissue erythema, edema and severe pain (70-80% of cases)
      1. Pain out of proportion to the exam
      2. Tenderness outside the erythematous borders
    3. Vessicles or Bullae (25%)
      1. Bullae become violaceous after 4-5 days
      2. Skin then becomes necrotic
      3. Hemorrhagic bullae are nearly pathognomonic for Necrotizing Fasciitis (esp. Vibrio vulnificus)
    4. Fever (40%)
      1. Temperature over 99.5 F (37.5 C)
    5. Tachycardia
      1. Unresponsive to Intravenous FluidResuscitation and antipyretics
    6. Hypotension (21%)
      1. Systolic Blood Pressure <90 mmHg
    7. Tissue Crepitation (20%)
      1. In Fournier's Gangrene, may not be readily evident (e.g. inguinal region or buttocks)
  12. Diagnosis: Definitive
    1. Deep tissue biopsy with culture and Gram Stain
  13. Labs
    1. LRINEC Score
      1. See Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC Score)
      2. High False Positive and False Negative Rate (misses up to 50% of cases)
    2. Complete Blood Count
      1. White Blood Cell Count over 15,000/mm3 (esp. if >25,000/mm3)
      2. Hemoglobin less than 11 g/dl
      3. Platelet Count <150,000 per mm3
    3. Serum Electrolytes
      1. Serum Sodium under 135 meq/L (SIADH related)
      2. Blood Urea Nitrogen 15 mg/dl
      3. Serum Calcium under 8.4 mg/dl
      4. Serum Creatinine >1.6 mg/dl
    4. Coagulation Studies
      1. Prothrombin Time (PT) prolonged
      2. Partial Thromboplastin Time (aPTT) prolonged
    5. Other markers
      1. C-Reactive Protein >150 mg/L
      2. Arterial or venous pH < 7.35
  14. Imaging
    1. Background
      1. Liquefaction necrosis and gas formation lead to many of the findings on imaging
    2. XRay
      1. Test Sensitivity: 25-50% for subcutaneous gas
      2. Test Specificity: 94%
      3. Gas along fascial planes is pathognomonic for Necrotizing Fasciitis (but a late finding)
      4. Negative xray does NOT exclude Necrotizing Fasciitis
    3. Ultrasound
      1. Consider in children, or in Ultrasound-guided fluid aspiration
      2. Fascial planes are thickened and distorted with fluid and subcutaneous edema
        1. Fluid at fascial layer 1 mm with Test Sensitivity 87%, Test Specificity 50%
        2. Fluid at fascial layer 5 mm with Test Specificity 98%
      3. Limited visualization if soft-tissue gas is present
        1. Gas-related shadowing appears as scattered clouds within tissue
    4. CT
      1. Soft tissue gas formation in subcutaneous and deep tissues
      2. Deep fascia contains fluid tracking around its planes (inconsistent)
      3. Superficial and deep fascial layers (as well as subcutaneous fat) with thickening and contrast enhancement
      4. Abscess may variably be present
      5. Reactive Lymphadenopathy
      6. Identitifies other complications (e.g. vascular rupture) as well as conditions in differential diagnosis
      7. CT is a first-line study in fourniers gangrene
        1. Contrast is not required for fourniers diagnosis, but contrast allows for differential diagnosis evaluation
    5. MRI
      1. Preferred imaging if no delay, and patient stable enough to withstand the lengthy study in the radiology department
      2. Efficacy
        1. Test Sensitivity: 100%
        2. Test Specificity: 86%
      3. Findings
        1. Fascial fluid (abnormally increased signal on T2-weighted images)
        2. Gas bubbles (variably present, signal voids on T1 and T2-weighted images)
        3. Reticular increased signal at subcutaneous tissues (similar to Cellulitis) as well as deep fascia involvement
          1. Deep intermuscular fascia involvement
          2. Fascial thickening (>3mm)
          3. Thickened fascia completely lacks signal enhancement post-Gadolinium
        4. Necrotic tissue is over-estimated as normal tissue may have a similar appearace on MRI
        5. Gadolinium is optional for diagnosis but assists in identifying abscesses, joint effusions
    6. References
      1. Malghem (2013) Joint Bone Spine 80(2): 146-54 [PubMed]
      2. Fugitt (2004) Radiographics 24(5): 1472-6 +PMID:15371620 [PubMed]
        1. https://pubs.rsna.org/doi/pdf/10.1148/rg.245035169
  15. Differential Diagnosis
    1. See Skin Infection (Pyoderma)
    2. Cellulitis
    3. Erysipelas
    4. Gas Gangrene (Clostridium perfringens)
    5. Pyomyositis (skeletal muscle abscess)
    6. Toxic Shock Syndrome
    7. Necrotizing Insect Bite (e.g. Brown Recluse Spider)
    8. Septic Superficial Thrombophlebitis
    9. Anaphylaxis
  16. Management: Surgical exploration to fascia and muscle
    1. Early exploration and surgical debridement within 12 hours is critical (delay risks higher mortality)
    2. Observe for
      1. Necrotizing Fasciitis
      2. Myositis
      3. Gangrene
    3. Technique
      1. Visualize deep structures
      2. Remove necrotic materials
      3. Reduce compartment pressure
      4. Send material for Gram Stain and Culture
  17. Management: Empiric
    1. Combination Regimen (3 drugs plus MRSA coverage)
      1. Anaerobe and Gram Positive coverage (and inhibits ribosomal production of toxins)
        1. Clindamycin 600 to 900 mg IV every 8 hours (40 mg/kg/day divided every 8 hours in children)
      2. Gram Positive coverage
        1. Ampicillin-sulbactam (Unasyn) 1.5 to 3 g IV every 6-8 hours OR
        2. Piperacillin-tazobactam 3.375 IV q6-8 hours
      3. Gram Negative coverage
        1. Ciprofloxacin 400 mg IV every 12 hours
    2. Combination Regimen (2 drugs plus MRSA)
      1. Cefotaxime 2 grams IV every 6 hours AND
      2. Anaerobic coverage
        1. Metronidazole 50 mg IV every 6 hours OR
        2. Clindamycin 600 mg IV every 8 hours
    3. Single agent regimens (choose one plus MRSA coverage)
      1. Imipenem-Cilastin 1 g IV every 6-8 hours
      2. Meropenem 1 g IV every 8 hours
      3. Ertapenem 1 g IV every 24 hours
    4. MRSA Coverage (use with above regimens)
      1. Vancomycin 15 mg/kg IV every 12 hours
      2. Linezolid 600 mg IV every 12 hours
      3. Clindamycin not typically recommended for MRSA as of 2015 due to growing resistance
        1. Review local antibiograms
    5. Other antibiotics
      1. Add Doxycycline if hemorrhagic bullae are seen (cover for Vibrio vulnificus)
    6. Other measures
      1. Maximize nutritional status
  18. Management: Post-exposure Prophylaxis
    1. Indications
      1. Household contact exposure from onset to 48 hours from antibiotic start
    2. Treatment options (choose one)
      1. Penicillin G Benzathine
        1. Weight <60 pounds (<27 kg): 600,000 units IM for 1 dose or
        2. Weight >60 pounds (<>7 kg): 1,200,000 units IM for 1 dose
      2. Rifampin 5 mg/kg/day (up to 300 mg maximum) orally twice daily for 4 days
      3. Clindamycin 20 mg/kg (up to 300 mg maximum) orally three times daily for 10 days
      4. Azithromycin (Zithromax) 12 mg/kg (up to 500 mg) orally daily for 5 days
    3. References
      1. Sablier (2010) Lancet 375(9719): 1052 [PubMed]
  19. Prognosis
    1. Mortality: 25-35% (up to 70% in those who develop Sepsis, 100% with delayed diagnosis, management)
    2. Truncal involvement mortality approaches 100%
    3. Hypotension is a strong predictor of multiorgan failure and death
  20. References
    1. Binder (2019) Crit Dec Emerg Med 33(9): 28-9
    2. Goldberg (2015) Crit Dec Emerg Med 29(3): 9-19
    3. Mason, Herbert and Swadron in Herbert (2019) EM:Rap C3 3(10): 1-12
    4. Jhun and Raam in Herbert (2016) EM:Rap 16(8): 9-10
    5. Inaba, Swadron, Long and Gottlieb in Herbert (2020) EM:Rap 20(10):10-11
    6. Elliott (2000) Am J Surg 179:361-6 [PubMed]
    7. Headley (2003) Am Fam Physician 68(2):323-8 [PubMed]
    8. Ramakrishnan (2015) Am Fam Physician 92(6): 474-83 [PubMed]
    9. Usatine (2010) Am Fam Physician 82(7): 773-80 [PubMed]
    10. Wall (2000) J Am Coll Surg 191:227-31 [PubMed]

Necrotizing fasciitis (C0238124)

Definition (NCI) Infection of the deep skin and subcutaneous tissues and necrosis of the fascia. It is caused by bacteria including group A streptococcus, Staphylococcus aureus and Clostridium perfringens. It may develop following trauma and invasive procedures.
Definition (MSH) A fulminating bacterial infection of the deep layers of the skin and FASCIA. It can be caused by many different organisms, with STREPTOCOCCUS PYOGENES being the most common.
Concepts Disease or Syndrome (T047)
MSH D019115
ICD9 728.86
ICD10 M72.6
SnomedCT 52486002, 186428007, 320701000009109
English Fasciitides, Necrotizing, Fasciitis, Necrotizing, Fascitides, Necrotizing, Fascitis, Necrotizing, Necrotizing Fasciitides, Necrotizing Fascitides, Necrotizing Fascitis, Streptococcal gangrene, Necrotizing fasciitis NOS, FASCIITIS NECROTISING, FASCIITIS NECROTIZING, necrotizing fasciitis, necrotizing fasciitis (diagnosis), Fasciitis necrotising, Necrotising fasciitis NOS, Fasciitis necrotizing, Necrotizing Fasciitis, Fasciitis, Necrotizing [Disease/Finding], necrotizing cellulitis, fasciitis necrotize, fascitis necrotizing, necrotizing myositis, streptococcal gangrene, necrotising fasciitis, fasciitis necrotising, fasciitis necrotizing, necrotizing fascitis, Necrotizing erysipelas, Necrotising erysipelas, Necrotising fasciitis (disorder), Necrotizing myositis, Necrotising cellulitis, Necrotising fasciitis, Necrotizing cellulitis, Necrotising myositis, Necrotizing fasciitis (disorder), Necrotizing fasciitis
Dutch necrotiserende fasciïtis NAO, necrotiserende cellulitis, fasciïtis necrotiserend, necrotiserende fasciïtis, Fasciitis necroticans, Necrotiserende fasciitis
French Cellulite nécrosante, Fasciite nécrosante SAI, FASCIITE NECROSANTE, Fasciite nécrosante, Cellulite gangréneuse, Fasciite gangréneuse, Gangrène sous-cutanée à streptocoques bêta-hémolytiques, Syndrome de Meleney
German Fasziitis nekrotisierend, nekrotisierende Zellulitis, nekrotisierende Entzuendung der Faszien NNB, nekrotisierende Fasziitis, Fasziitis, nekrotisierende
Italian Fascite necrotizzante NAS, Cellulite necrotizzante, Fascite necrotizzante
Portuguese Celulite necrosante, Fasceíte necrosante, Fasceíte necrosante NE, FASCEITE NECROSANTE, Fasciite necrotizante, Fasciite Necrosante
Spanish Fascitis necrotizante, Celulitis necrotizante, Fasciitis necrosante, Fasciitis necrotizante NEOM, Fascitis necrosante, miosistis necrotizante, erisipela necrotizante, erisipela necrosante, fascitis necrosante (trastorno), fascitis necrosante, fascitis necrotizante, miositis necrosante, Fasciitis necrotizante, Fascitis Necrotizante
Russian НЕКРОТИЧЕСКАЯ ФОРМА РОЖИ, NEKROTICHESKAIA FORMA ROZHI, ROZHI NEKROTICHESKAIA FORMA, FASTSIT NEKROTICHESKII, РОЖИ НЕКРОТИЧЕСКАЯ ФОРМА, ФАСЦИТ НЕКРОТИЧЕСКИЙ
Japanese 壊死性筋膜炎NOS, 壊死性蜂巣炎, エシセイキンマクエン, エシセイホウソウエン, エシセイキンマクエンNOS, 筋膜炎-壊死性, 壊死性筋膜炎
Swedish Fascit, nekrotiserande
Czech fasciitida nekrotizující, Nekrotizující celulitida, Nekrotizující fasciitida, Nekrotizující fasciitida NOS
Finnish Nekrotisoiva faskiitti
Korean 괴사 근막염
Polish Zapalenie powięzi martwicze
Hungarian necrotizáló fasciitis, cellulitis necrotisans, Necrotizáló fasciitis k.m.n., Fasciitis necrotisans, Necrotizáló cellulitis, Nekrotizáló fasciitis
Norwegian Nekrotiserende fasciitt, Fasciitt, nekrotiserende
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Fournier Gangrene (C0238419)

Definition (MSHCZE) Infekce skrota a hráze pokračující do gangrény, vyvolaná smíšenou bakteriální flórou a kandidou. Zejm. u diabetiků. (cit. Velký lékařský slovník online, 2013 http://lekarske.slovniky.cz/ )
Definition (MSH) An acute necrotic infection of the SCROTUM; PENIS; or PERINEUM. It is characterized by scrotum pain and redness with rapid progression to gangrene and sloughing of tissue. Fournier gangrene is usually secondary to perirectal or periurethral infections associated with local trauma, operative procedures, or urinary tract disease.
Concepts Disease or Syndrome (T047)
MSH D018934
ICD10 N49.3
SnomedCT 398318005, 236742003
English Fournier Disease, Fournier Gangrene, Fournier's Disease, Fournier's Gangrene, Fourniers Disease, Fourniers Gangrene, Gangrene, Fournier's, FOURNIERS DIS, FOURNIER DIS, Gangrene, Fournier, Fournier gangrene, Fournier Gangrene [Disease/Finding], fournier disease, fournier gangrene, fournier's gangrene, fourniers gangrene, fourniers disease, gangrene fournier's, fournier's disease, fournier gangrene (diagnosis), Fournier's gangrene, Fournier's gangrene (disorder), Fournier; gangrene, gangrene; Fournier
German Fournier-Gangraen, Fournier-Krankheit, Fournier-Gangrän, Skrotalgangrän
Japanese フルニエー壊疽, フルニエーエソ, Fournier壊疽, Fournier病, フルニエ壊疽, フルニエ病
Swedish Fourniers gangrän
Czech Fournierova nemoc, Fournierova gangréna
Finnish Fournierin gangreeni
Russian GANGRENA FURN'E, FURN'E BOLEZN', FURN'E GANGRENA, ГАНГРЕНА ФУРНЬЕ, ФУРНЬЕ БОЛЕЗНЬ, ФУРНЬЕ ГАНГРЕНА
Italian Malattia di Fournier, Gangrena di Fournier
Croatian FOURNIEROVA GANGRENA, GANGRENA FOURNIER
Polish Choroba Fourniera, Zgorzel Fourniera, Zgorzel moszny
Hungarian Fournier-gangraena
Norwegian Fourniers sykdom, Fourniers gangren
Dutch Fournier; gangreen, gangreen; Fournier, Fournier-gangreen, Fournier-ziekte, Gangreen, Fournier-
Spanish gangrena de Fournier (trastorno), gangrena de Fournier, Gangrena de Fournier, Enfermedad de Fournier
French Gangrène de Fournier, Gangrène génitale, Gangrène périnéo-scrotale, Gangrène périnéoscrotale, Maladie de Fournier
Portuguese Doença de Fournier, Gangrena de Fournier
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Streptococcal necrotizing fasciitis (C0854084)

Concepts Disease or Syndrome (T047)
SnomedCT 449900006
Italian Fascite necrotizzante streptococcica
French Fasciite nécrosante à streptocoques, Fasciite nécrosante streptococcique
Spanish Fascitis necrosante por estreptococos, fascitis necrosante debida a Streptococcus pyogenes, fascitis necrosante debida a Streptococcus pyogenes (trastorno), gangrena estreptocócica, Fasciitis necrosante estreptocócica
Japanese レンサ球菌性壊死性筋膜炎, レンサキュウキンセイエシセイキンマクエン
Czech Streptokoková nekrotizující fasciitida
English Necrotising fasciitis streptococcal, Necrotizing fasciitis streptococcal, Necrotizing fasciitis due to Streptococcus pyogenes, Type II necrotising fasciitis, Streptococcal gangrene, Streptococcal necrotising fasciitis, Necrotizing fasciitis due to Streptococcus pyogenes (disorder), Type II necrotizing fasciitis, Necrotising fasciitis due to Streptococcus pyogenes, Streptococcal necrotizing fasciitis, necrotizing fasciitis due to streptococcus pyogenes (diagnosis)
Hungarian streptococcalis necrotizáló fasciitis, Necrotizáló streptococcalis fasciitis
Portuguese Fasceíte necrosante estreptocócica
Dutch necrotiserende streptokokkenfasciïtis
German nekrotisierende Fasziitis durch Streptokokken
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree